# Effect of Endostar Combined With Chemotherapy and Radiotherapy on Blood Vessels and Microenvironment of Tumor for Non-small Cell Lung Cancer (NSCLC)

> **NCT01687439** · PHASE2 · COMPLETED · sponsor: **Fudan University** · enrollment: 15 (actual)

## Conditions studied

- Non-small Cell Lung Cancer

## Interventions

- **DRUG:** Endostar
- **DRUG:** Vinorelbine
- **DRUG:** Cisplatin
- **RADIATION:** Radiotherapy

## Key facts

- **NCT ID:** NCT01687439
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2009-10
- **Final completion:** 2009-10
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2012-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01687439

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01687439, "Effect of Endostar Combined With Chemotherapy and Radiotherapy on Blood Vessels and Microenvironment of Tumor for Non-small Cell Lung Cancer (NSCLC)". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT01687439. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*